Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimal Stimulation for IVF Hypo-responders
NCT07121751Phase 4Not yet recruiting
- Sponsor
- Istenhegyi IVF Centrum
- Start
- Sep 2025
- Primary completion
- Aug 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of follitropin alfa, lutropin alfa and follitropin delta in infertility (3 arms), sponsored by Istenhegyi IVF Centrum. Primary endpoint: Live clinical pregnancy. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
follitropin alfalutropin alfafollitropin delta
03
Conditions
infertility
Beyond the preview
Go deeper on NCT07121751.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07121751.